Zimmer Biomet Holdings (NYSE: ZBH) reported Q3 EPS of $1.77, $0.02 better than the analyst estimate of $1.75. Revenue for the quarter came in at $1.89 billion versus the consensus estimate of $1.87 billion.

"Our global team delivered strong results this quarter, fueled by a clear focus on our strategic priorities and key new product introductions," said Bryan Hanson, President and CEO of Zimmer Biomet. "I'm excited by the momentum across the organization and am grateful for the commitment and winning spirit from our team members around the world."

For earnings history and earnings-related data on Zimmer Biomet Holdings (ZBH) click here.